Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 601–700 of 786
Gutiérrez, M. Á. M., Castiella, I. F., Gros, P. B., Anca, S. G., Fresno, P., Domínguez, J. A. R., Barriocanal, M. B., Lavisier, B. D. M., López, R. L., Sánchez, P. G., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05100-0 · Cited by 3
Structural impact of synonymous mutations in six SARS-CoV-2 Variants of Concern
Ziesel, A., & Jabbari, H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325858 · Cited by 4
Notable Variants of SARS-CoV-2
Naji, H. S. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.2.742 · Cited by 3
Reverse spillover of SARS-CoV-2 from human to wild animals
Li, M., Cheng, X., & Qin, C. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2124-y · Cited by 3
Self-citationIn Silico Evaluation of CRISPR-Based Assays for Effective Detection of SARS-CoV-2
Kaewsapsak, P., Chantaravisoot, N., Nimsamer, P., Mayuramart, O., Mankhong, S., & Payungporn, S. (2022) · Pathogens · doi:10.3390/pathogens11090968 · Cited by 3
Broad Spectrum Antiviral Therapy can Supersede Vaccination Strategy for Combating COVID-19 Pandemic
Chakraborty, A. K. (2021) · Medical Journal of Clinical Trials & Case Studies · doi:10.23880/mjccs-16000298 · Cited by 4
Assessment of the Prevalence and Incidence of COVID-19 in Saudi Arabia
Alyahyawi, H. E., Alharbi, R., Alatawi, S. K., Ahmed, W. A. M., & Almalki, S. S. R. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s394038 · Cited by 3
Animal Models for Long COVID: Current Advances, Limitations, and Future Directions
Zhang, Y., Chen, H., Li, Y., Luo, C., Zhu, Y., Zhou, X., Wang, R., He, J., Guo, H., Xu, X.-F., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70237 · Cited by 3
Self-citationSARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner
Kobayashi, M., Kobayashi, N., Deguchi, K., Omori, S., & Ichinohe, T. (2025) · npj Vaccines · doi:10.1038/s41541-025-01095-z · Cited by 3
Xu, Z., Li, L., Gu, Y., Li, D., Qi, J., Liu, K., Deng, C., & Gao, G. F. (2025) · Journal of Virology · doi:10.1128/jvi.00283-25 · Cited by 3
Design of specific primer sets for SARS-CoV-2 variants using evolutionary algorithms
Lopez‐Rincon, A., Perez-Romero, C. A., Mendoza‐Maldonado, L., Claassen, E., Garssen, J., Kraneveld, A. D., & Tonda, A. P. (2021) · Genetic and Evolutionary Computation Conference (GECCO) · doi:10.1145/3449639.3459359 · Cited by 3
Watson, M. E., Inagaki, K., & Weinberg, J. B. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000011 · Cited by 3
In silico design of miniprotein to inhibit SARS-CoV-2 variant Omicron spike protein
Wu, J., Zhang, H., & Zhang, J. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp01167d · Cited by 3
Qing, H., Sharma, L., Hilliard, B. K., Peng, X., Swaminathan, A., Tian, J., Israni-Winger, K., Zhang, C., Leão, D. P., Ryu, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.11.294231 · Cited by 3
Rapidly Deployable Mouse Models of SARS-CoV-2 Infection Add Flexibility to the COVID-19 Toolbox
Harker, J. A., & Johansson, C. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0456ed · Cited by 3
Rego, N., Fernández-Calero, T., Arantes, I., Noya, V., Mir, D., Brandes, M., Zanetti, J., Arleo, M., Pereira-Flores, E., Possi, T., et al. (2021) · medRxiv · doi:10.1101/2021.07.05.21259760 · Cited by 4
Tarrés-Freixas, F., Trinité, B., Pons-Grífols, A., Romero‐Durana, M., Riveira‐Muñoz, E., Ávila‐Nieto, C., Pérez, M., García-Vidal, E., Perez‐Zsolt, D., Muñoz‐Basagoiti, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.03.454861 · Cited by 3
Impaired immune response drives age-dependent severity of COVID-19Preprint
Beer, J., Crotta, S., Breithaupt, A., Ohnemus, A., Becker, J., Sachs, B., Kern, L., Llorian, M., Ebert, N., Labroussaa, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.21.489072 · Cited by 3
COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects
Wang, S., Li, L., Yan, F., Gao, Y., Yang, S., & Xia, X. (2021) · Vaccines · doi:10.3390/vaccines9101082 · Cited by 25
Brugère‐Picoux, J., Leroy, E. M., Rosolen, S. G., Angot, J.-L., & Buisson, Y. (2021) · Bulletin de l Académie vétérinaire de France · doi:10.3406/bavf.2021.70954 · Cited by 2
Shipovalov, A. V., Kudrov, G. A., Kartashov, M. Y., Drachkova, I. A., Pyankov, O. V., Omigov, V. V., Taranov, O. S., & Teplyakova, T. V. (2023) · Problems of Virology · doi:10.36233/0507-4088-168 · Cited by 2
Babar, Q. A., Saeed, A., Bashir, M., Niaz, K., Rafiq, M., Waqas, M. Y., Tahir, M. F., Aqib, A. I., Dilawar, M., & Nisar, M. F. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815322194125010006 · Cited by 2
Mantuano, N. R., Bärenwaldt, A., Sarcevic, M., Siqueira, I. V. M., Jauch, A., Etter, M. M., Matter, M. S., Hütter, G., Recher, M., & Laubli, H. P. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf340 · Cited by 4
Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2
Moore, K. M., Foster, S. L., Kar, M., Floyd, K. A., Elrod, E. J., Williams, M. E. K., Velden, J. W. V., Ellis, M. L., Malik, A. A., Wali, B., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013752 · Cited by 2
Gibson, K., Li, P., Li, V., Dix, M., Hung, L.-W., Stelle, G. W., Babinski, M., Chain, P. S. G., & Hu, B. (2026) · BMC Genomics · doi:10.1186/s12864-026-12976-5 · Cited by 2
Predictive Models of within- and between-Species SARS-CoV-2 Transmissibility
Soares, R., Vieira, C. P., & Vieira, J. (2022) · Viruses · doi:10.3390/v14071565 · Cited by 3
Smither, S. J., Kempster, S. L., Priestnall, S. L., Suárez‐Bonnet, A., Stapleton, H. L., Laws, T. R., Ferguson, D., Almond, N. M., Lever, M. S., & Williamson, E. D. (2022) · Viruses · doi:10.3390/v14081769 · Cited by 2
Reggiani, A., Rugna, G., & Bonilauri, P. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1085613 · Cited by 2
Jaishwal, P., Gyaneshwari, U., Jha, K., Pandey, B., Yadav, T. P., & Singh, S. P. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.90 · Cited by 2
Pan, R., Meyerholz, D. K., & Perlman, S. M. (2025) · mBio · doi:10.1128/mbio.03693-24 · Cited by 3
Abbad, A., Yueh, J., Yellin, T., Singh, G., Carreño, J. M., Clark, J. J., Muramatsu, H., Tiwari, S., Bhavsar, D., Alzua, G. P., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2025.126825 · Cited by 2
Theories of the origin of SARS-CoV-2 in the light of its continuing evolution
Débarre, F., & Hensel, Z. (2025) · Comptes Rendus Biologies · doi:10.5802/crbiol.183 · Cited by 3
Zoest, V. P., Lee, W. S., Murdiyarso, L., Burmas, L., Pymm, P., Esterbauer, R., Kelly, A. P., Kelly, H. G., Barber-Axthelm, I. M., Cooney, J. P., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01323-6 · Cited by 2
Zhang, Z., Zhang, L., Zhu, A., Wang, Y., Guan, W., Zeng, Z., Sun, J., Li, F., Zhao, J., Yang, Z., et al. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-2084 · Cited by 3
Self-citationИванович, В. В., Николаевич, В. В., & Shabanov, P. D. (2020) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf184269-296 · Cited by 2
Shahriar, A., Mahmud, A. R., Ahmed, H. M., Rahman, N., & Khatun, M. C. (2021) · Austin Journal of Microbiology · doi:10.26420/austinjmicrobiol.2021.1028 · Cited by 3
Liu, L., Luo, T., Lei, G., Feng, Y., Zhao, X., Yang, H., Xu, J., Pan, M., & Zhou, L. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.155 · Cited by 2
Li, X., Gao, X., Zou, M., Zhuang, Z., Tan, Z., Zheng, B., Yu, A., & Su, X. (2021) · Virologica Sinica · doi:10.1007/s12250-021-00432-5 · Cited by 2
Self-citationFatores de virulência microbianos e terapias emergentes
Barbosa, A. V., da Silva, S. M., da Silva, F. H. S., de Assunção, M. A. S., & dos Anjos, F. B. R. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000093 · Cited by 2
Multiplex Quantitative Polymerase Chain Reaction Test to Identify SARS-CoV-2 Variants
Hawkins, S. F. C., & Guest, P. C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2395-4_5 · Cited by 2
Morphological appearance of the B.1.1.7 mutation of the novel coronavirus 2 (SARS-CoV-2) in chest CT
Kottlors, J., Fervers, P., Geißen, S., Gertz, R. J., Bremm, J., Rinneburger, M., Weisthoff, M., Shahzad, R., Maintz, D. C., & Persigehl, T. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-718 · Cited by 3
Jacob, R. A., Zhang, A., Ajoge, H. O., D’Agostino, M. R., Nirmalarajah, K., Shigayeva, A., Demian, W. L., Baker, S. J. C., Derakhshani, H., Rossi, L., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2907.230198 · Cited by 2
Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2
Yang, R., Han, P., Han, P., Li, D., Zhao, R., Niu, S., Liu, K., Li, S., Tian, W., & Gao, G. F. (2024) · Journal of Virology · doi:10.1128/jvi.00451-24 · Cited by 2
Epidemic trends of SARS-CoV-2 modulated by economic activity, ethnicity, and vaccinationPreprint
Kamikubo, Y., & Takahashi, A. (2021) · doi:10.33774/coe-2021-xfgln · Cited by 2
Carvalho, P. P. D. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2021.tde-24082021-145318 · Cited by 3
Mapping the Non-Structural Transmembrane Proteins of SARS-CoV-2Preprint
Thomas, S. (2022) · Preprints.org · doi:10.20944/preprints202012.0366.v2 · Cited by 2
LY6E protects mice from pathogenic effects of murine coronavirus and SARS-CoV-2Preprint
Mar, K. B., Dyke, M. C. C. V., Lopez, A. H., Eitson, J. L., Fan, W., Hanners, N. W., Evers, B. M., Shelton, J. M., & Schoggins, J. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.25.525551 · Cited by 4
Generation of a biosafety mouse model infection for SARS-CoV-2 replicon delivery particlesPreprint
Li, Y., Huang, X., Deng, J., Tan, X., Liu, Q., Zhou, L., & Chen, Y. Z. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.10.622838 · Cited by 2
Self-citationWangsanegara, R. B. M., Suroso, A. I., & Sartono, B. (2024) · International Journal of Research and Review · doi:10.52403/ijrr.20240228 · Cited by 1
Hansur, L., Louisa, M., Ernawaty, B., Wuyung, P. E., Zaini, J., Fadillah, F., & Wibowo, H. (2024) · AIP conference proceedings · doi:10.1063/5.0199399 · Cited by 1
Translational research on pandemic virus infection using nonhuman primate models
Ishigaki, H., & Itoh, Y. (2025) · Virology · doi:10.1016/j.virol.2025.110511 · Cited by 2
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2
Kondo, T., Suzuki, R., Yajima, H., Kawahara, S., Yamaya, K., Ichikawa, T., Tsujino, S., Suzuki, S., Tamura, T., Hashiguchi, T., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00543-25 · Cited by 3
Bi, Z., Ren, W., Zeng, H., Zhou, Y., Liu, J., Chen, Z., Zhang, X., He, X., Lu, G., Wei, Y., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70060 · Cited by 1
Self-citationCharacterization of a SARS-CoV-2 infection model in golden hamsters with diabetes mellitus
Lin, H., Jiang, R.-D., Qin, R.-X., Yao, B., Zeng, W., Gao, Y., Shi, A.-M., Li, J., & Liu, M. (2025) · Virologica Sinica · doi:10.1016/j.virs.2025.05.001 · Cited by 1
Self-citationWang, S., Hao, Z., Ding, Y., Rong, H., Ning, S., Qiao, Q., Zhu, X., Wu, T., Zhao, K., Zhu, L., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11414-3 · Cited by 1
Self-citationWu, L., Tao, Y., Wu, X., Li, S., Yang, R. F., Li, C., Yao, Y., Xu, S., Shu, J., He, Y., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13092009 · Cited by 1
Self-citationLiu, G., Yuan, Z., Wu, Z., Yang, Q., Ding, T., Yu, K., & Dong, J. (2025) · Vaccines · doi:10.3390/vaccines13090977 · Cited by 2
Harbach, S. L., Tran, B. M., Hachani, A., Grimley, S. L., Purcell, D. F. J., Deliyannis, G., Torresi, J., McAuley, J., & Vincan, E. (2025) · Organoids · doi:10.3390/organoids4030021 · Cited by 1
Liu, F., Xia, Y., Lee, A. C.-Y., Chen, Y., Chen, Z., He, Y., Chan, C. H.-C., Cai, J., Yuen, T. T., Ye, Z., et al. (2026) · npj Viruses · doi:10.1038/s44298-026-00181-w · Cited by 1
Self-citationTodd, A. W., Shein, S. A., Korchagina, A. A., Kudinov, V. A., Faz, B. N., Barre, R. S., Paik, R., Collins, E. C., Yusoof, K. A., Khetarpal, I., et al. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.04.001 · Cited by 1
Vaccine Development and Immune Responses in COVID-19: Lessons from the Past
Fatemi, F., Nejad, Z. H., & Siadat, S. E. R. (2021) · Springer eBooks · doi:10.1007/978-981-16-3108-5_5 · Cited by 1
Bioinformatic and MD Analysis of N501Y SARS-CoV-2 (UK) Variant
Jukič, M., Kralj, S., Nikitina, N., & Bren, U. (2021) · IFIP advances in information and communication technology · doi:10.1007/978-3-030-86582-5_1 · Cited by 1
The N501Y Mutation of SARS-CoV-2 Spike Protein Impairs Spindle Assembly in Mouse Oocytes
Liu, H., Shi, J., Fok, K. L., & Chen, H. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00809-7 · Cited by 1
Gao, L., Zu, X., Liu, X., Yu, Z., Du, Z., Hu, Z., & Xue, Y. (2022) · Micromachines · doi:10.3390/mi13020145 · Cited by 1
Advances in Modelling COVID-19 in Animals
Nickl, P., Raishbrook, M. J., Syding, L. A., & Sedláček, R. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.899587 · Cited by 1
[Investigation of Virulence Variation of Enterovirus 71 Strains during Thermal Adaptive Evolution].
Chen, H., Cheng, Y., Meng, J., Huang, W., Huang, W., Chen, Z., Zhang, X., Yuan, Q., & Wang, X.-X. (2022) · 四川大学学报:医学版 · doi:10.12182/20220560104 · Cited by 1
Self-citationPreliminary Step towards COVID-19 Inactivated Vaccine Development in Egypt
Saad, M. A., Saleh, A. A., Ryan, I., Amin, M., Saleh, M. S., Abdulaal, T., Hassan, W. A., Samir, M., Raouf, A. A., Khattab, A., et al. (2021) · Archives of Clinical Trials · doi:10.33425/2768-4598.1001 · Cited by 1
Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021
Payen, S. H., Gorzalski, A. J., Siao, D. D., Pandori, M., Verma, S. C., & Rossetto, C. C. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105434 · Cited by 1
Cao, J., Gu, H., Zhang, X., Yun, H., Li, J., Si, C.-Y., Zhang, J., & Wang, H. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199201 · Cited by 1
Self-citationNychyk, S. A., Mandygra, M., Bezymennyi, M., Hudz, N. V., Molozhanova, A. V., & Тарасов, О. А. (2024) · Agricultural science and practice · doi:10.15407/agrisp10.03.003 · Cited by 1
Shape variation in cranium, mandible and teeth in selected mouse strains
Ağaç, D. K., Oktay, E., Onuk, B., Kabak, M., & Gündemir, O. (2024) · Anatomia Histologia Embryologia · doi:10.1111/ahe.13064 · Cited by 2
Visualizing of engineered five-helix bundle protein for blocking SARS-CoV-2 variants in live animals
Xian, J., Li, Z., Huang, H., Bi, L., Guan, Z., Huang, G., Yang, M., Gao, Z., Yao, J., Su, Z., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155827 · Cited by 1
López, L., & Rodó, X. (2024) · Ecological Informatics · doi:10.1016/j.ecoinf.2024.102827 · Cited by 1
Sun, H., Liu, K., Yu, B., Zhu, M., Jia, L., Yao, W., Chen, Z., Hao, H., Zhang, X., Liu, Y., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70049 · Cited by 3
Li, Q., Cai, X., Li, X., Zhang, Y.-B., Li, R., Kang, Z., Wan, D., Wang, J., Li, L., Yang, J., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01007-25 · Cited by 2
Self-citation19. Einsatz gentechnologischer Methoden in der Impfstoffentwicklung gegen das SARS-CoV-2-Virus
Körte, M. (2021) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783748927242-415 · Cited by 1
Emerging SARS-CoV-2 variants expand species tropism to rodentsPreprint
Shuai, H., Chan, J. F., Yuen, T. T., Yoon, C., Hu, J., Wen, L., Hu, B., Yang, D., Wang, Y., Hou, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-676992/v1 · Cited by 1
Self-citationBolkhovitina, E. L., Vavilova, J. D., Bogorodskiy, A. O., Zagryadskaya, Y. A., Okhrimenko, I. S., Sapozhnikov, A. M., Borshchevskiy, V. I., & Shevchenko, M. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.488042 · Cited by 1
Why new COVID-19 variants are on the rise and spreading around the world
Otto, S. P. (2021) · The Conversation · doi:10.64628/aam.3em5gshds · Cited by 1
An engineering model of the COVID-19 trajectory to predict the success of isolation initiatives
King, S., & Striolo, A. (2021) · UCL Open Environment · doi:10.14324/111.444/ucloe.000020 · Cited by 2
Interactive SARS-CoV-2 mutation timemaps
Warren, R. L., & Birol, İ. (2021) · F1000Research · doi:10.12688/f1000research.50857.2
Uneven growth of SARS-CoV-2 clones evidenced by more than 500,000 whole-genome sequencesPreprint
Zeng, H.-L., Liu, Y., Thorell, K., Nordén, R., & Aurell, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.06.437914 · Cited by 1
The Genetic Diversity Mice Models in SARS-CoV-2 InfectionPreprint
Wang, X., Liu, Y., Qu, Y., Hou, R., Liu, J., Gao, R., Bao, L., Deng, W., Cao, Y., Li, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-437876/v1
Self-citationPolysulfate hemmen durch elektrostatische Wechselwirkungen die SARS‐CoV‐2‐Infektion**
Nie, C., Pouyan, P., Lauster, D. C., Trimpert, J., Kerkhoff, Y., Szekeres, G. P., Wallert, M., Block, S., Sahoo, A. K., Dernedde, J., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202102717
Lobanova, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824409-8.00007-2 · Cited by 2
COVID-19 variants, available treatments, and vaccinations: An overview study
Mohammed, A. H., Suhaimi, A. M., & Hassan, B. A. R. (2021) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v1i.42 · Cited by 1
同潤会江戸川アパートメントの建替え計画の変遷に関する研究(建替え・ストック改善,建築計画II)
篠原, 靖., 大月, 敏., & 安武, 敦. (2002) · 学術講演梗概集. E-2, 建築計画II, 住居・住宅地, 農村計画, 教育
State-of-the-art preclinical evaluation of COVID-19 vaccine candidates
Ghosh, D., Bai, B., Ji, Q., Palliyil, S., Yang, G., Kumar, A., & Saxena, A. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00030
Self-citationMeet the Honorary Senior Advisor
Jiang, S. (2022) · Current Chinese Science · doi:10.2174/221029810201220316093747
Self-citationA systematic review of the variants of Sars-Cov-2
Qureshi, M. F., & Qureshi, S. (2022) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2022.5.2.0050
RELAÇÃO ESTRUTURA-ATIVIDADE DE FÁRMACOS ANTI-HIV DISPONIBILIZADOS PELO SISTEMA ÚNICO DE SAÚDE (SUS)
de Lira, M. F., de Melo, B. M. T., de Oliveira, L. L., Bezerra, C. D. O., Coutinho, F. N., & de Faria, A. R. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000107
DESAFIOS DO VÍRUS DA DENGUE NO MOSQUITO VETOR
Gonçalves, G. G. A., Feitosa, A. P. S., Brayner, F. A., & Alves, L. C. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000103
UMA BREVE ABORDAGEM DE LECTINA COM ATIVIDADE ANTI-SARS-CoV-2/COVID-19
Cintra, A. J. L., Torres‐León, C., Neves, J. L., & Correia, M. T. D. S. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000097
TERAPIAS ANTIVIRAIS: DA VACINA A NOVAS ABORDAGENS TERAPÊUTICAS
de Araújo, A. J. M., Bandeira, R. C. D. S., de Mélo, S. G. R., Calado, C. M. S. D. S., & Barbosa, A. V. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000109
da Costa, L. A. G., de Souza, C. G., Ferreira, A. S., de Araújo, L. V., Souza, A. T. M., & Neto, P. J. R. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000111
Bernardo, R. N., Aguiar, M. A. M. D. S., Ferreira, A. L., & dos Santos, K. M. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000100
COVID-19: IMPORTÂNCIA E AVANÇOS NO DIAGNÓSTICO DA DOENÇA
da Rosa, M. M., Pereira, M. C., Cunha, E. G. C., Albuquerque, A. P. D. B., de Oliveira, P. S. S., Carvalho, L. V. D. N., Tavares, L. B., Costa, N. T. C., de Paula, S. K. S., de Carvalho, V. M. F., et al. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000094
ARBOVIROSES: ASPECTOS VIRAIS, ECOLÓGICOS, CLÍNICOS E EPIDEMIOLÓGICOS
de Oliveira, M. E. D. S. P., de Lima, M. V. D. S. A., de Assunção, M. A. S., & LIMA, V. K. D. A. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000102
CHIKUNGUNYA: DA EPIDEMIOLOGIA AO DESENVOLVIMENTO DE VACINAS
Purificação, A., Azevedo, E. D. A. N., Lins, R. D., & Viana, I. F. T. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000105
FATORES DE VIRULÊNCIA VIRAIS NA COVID-19
Farias, P. C. S., da Rocha, D. A. M., Feitosa, A. P. S., Alves, L. C., & Brayner, F. A. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000096
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.